We're working on profiling this company soon. Let us know you're interested by sending us a request here »
We're working hard to bring you this company's profile. Register here to get an alert as soon we're done.
In the meantime, if you are interested in participating in placements on this stock click "Follow" on the toolbar above.
It was a positive start to the week for the Australian bourse. The ASX 200 rose 0.22% to 7,505 while...
Read ArticleOne of the inconveniences of COVID-19 tests is that they can take several hours to complete. A numbe...
Read ArticleTwo COVID-19 antibody kits have failed post-market testing, raising more questions about the 20 poin...
Read ArticleAs could be expected, the molecular diagnostics house’s announcement of European approval of its Chi...
Read ArticleIt’s tough to sell anything in a foreign market if you can’t even get out of your home market, and t...
Read ArticleThe market for COVID-19 diagnostic kits is much broader than just the health sector, as miners and o...
Read ArticleDespite March being a tough month to raise capital for ASX small caps, the money was still flowing f...
Read ArticleBefore 1942, Australia hadn’t fully come to terms with what a world war would require it to do. By t...
Read ArticleEach Monday, Stockhead recaps which stocks are most heavily in demand by investors — running hot. Th...
Read ArticleThe ASX is cracking down on biotech and health companies disclosures around possible coronavirus-lin...
Read ArticleThe corporate watchdog is examining suspicious trading in TBG Diagnostics Limited after its shares j...
Read ArticleHere’s our fortnightly wrap of all the news driving ASX health stocks. Of the ASX’s 137-odd small ca...
Read ArticleWe now know why TBG Diagnostics (ASX:TDL) shares more than doubled this week: it has European approv...
Read ArticleMelbourne-based biotech firm TBG Diagnostics Ltd [ASX:TDL] (formerly Progen Pharmaceuticals Ltd) saw...
Read ArticleHere’s our fortnightly wrap of all the news driving ASX health stocks. Of the ASX’s 137-odd small ca...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read Article
Open an account with an online broker of your choice. If you do not have an existing broker, consider Vested Equities' A$9.50 flat fee platform.
Sign up now »Place your order however you wish. If you need advice on buying or selling, you should seek the assistance of a full service financial adviser experienced in small cap equities.
